NCT03193970 Measuring Surgical Recovery After Radical Cystectomy
| NCT ID | NCT03193970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Bladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2015-04-30 |
| Primary Completion | 2034-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2015-04-30 with a primary completion date of 2034-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.
Eligibility Criteria
Inclusion Criteria: 1\. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers. Exclusion Criteria: N/A
Contact & Investigator
Neema Navai, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT03193970 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03193970 currently recruiting?
Yes, NCT03193970 is actively recruiting participants. Contact the research team at nnavai@mdanderson.org for enrollment information.
Where is the NCT03193970 trial being conducted?
This trial is being conducted at Stanford, United States, Atlanta, United States, Chicago, United States, Lawrence, United States and 6 additional locations.
Who is sponsoring the NCT03193970 clinical trial?
NCT03193970 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Neema Navai, MD at M.D. Anderson Cancer Center. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.